Đang chuẩn bị liên kết để tải về tài liệu:
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: A retrospective cohort study

Trabectedin is an antineoplastic agent used for patients with soft tissue sarcoma (STS) who fail standard-of-care treatment. Real-world data of its performance is scarce. This study evaluates the safety and effectiveness of trabectedin for patients with advanced STS who were treated at a high-volume sarcoma center. |